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Introduction
Acute viral hepatitis A rarely manifests with
neurological symptoms or brain abnormalities,1
and many infections can be subclinical. The present
study describes a patient who, after magnetic
resonance imaging (MRI), was found to have an
isolated focal lesion in the splenium of the corpus
callosum, and who was diagnosed with acute viral
hepatitis A infection.
Case report
A 15-year-old female was admitted to our hospital suffering loss
of consciousness and fever. She had been healthy 3 days before
admission when she developed a high fever, headache, nausea,
vomiting and myalgia. She had a history of febrile convulsions,
but no subsequent history of seizures or family history of
seizures. On the morning of the day of admission, she lost
consciousness for several seconds three times. She did not notice
any preceding symptoms. There were no convulsive movements,
urinary incontinence or tongue biting.
On admission, physical examination showed no abnormalities
except for a body temperature of 40 8C. Her nutritional status
was good, although she had nausea and vomiting for 3 days.
Neurological and cognitive function tests showed normal results.
Laboratory findings were (normal ranges given in parentheses):
AST 1948 IU/l (,40 IU/l), ALT 1606 IU/l (,40 IU/l), alkaline
phosphatase 81 IU/l (40–120 IU/L), g-GTP 106 IU/l (8–35 IU/l),
total bilirubin 1.9 mg/dl (0.2 –1.2 mg/dl), direct bilirubin
0.8 mg/dl (,0.5 mg/dl) and ammonia 55 umol/l (10 –
35 mmol/l). Viral markers of hepatitis A, B, C and E were all
negative. Epstein-Barr virus and cytomegalovirus antibodies and
the Widal test were all negative. Blood cultures showed no
growth. Cerebrospinal fluid (CSF) analysis was normal. CSF viral
markers for herpes simplex virus I and II, and cytomegalovirus
were negative. In addition, the CSF did not contain antibodies
against Streptococcus B spp., Haemophilus spp., pneumococcus
or meningococcus. Electrocardiography showed normal sinus
rhythm and electroencephalography (EEG) findings were normal.
Brain MRI on the second day after admission showed a focal high-
intensity signal limited to the splenium of the corpus callosum on
the T2-weighted and fluid-attenuated inversion recovery (FLAIR)
images (Fig. 1). There was no enhancement.
Seven days later, follow-up viral markers for hepatitis were
positive for the IgM antibody against hepatitis A. Acute viral
hepatitis A was diagnosed. The patient was discharged 14 days
after admission as the liver enzyme levels gradually normalized
and clinical symptoms improved. Follow-up brain images after 1-
year demonstrated that the splenial lesion had completed
resolved, and she was healthy without subsequent loss of
consciousness and no deficit.
Discussion
In the present case, a diagnosis of acute viral
hepatitis A infection was made based on serocon-
version of IgM antibodies against hepatitis A. The
transient lesion visualized using MRI might have
been caused by acute viral hepatitis A per se, or
have been related to the recurrent episodes of loss
of consciousness. As the CSF tests and the EEG
showed normal results, there was no clear evidence
for brain involvement of the acute viral hepatitis A
infection. Therefore, the corpus callosum lesion
might have been oedema related to the loss
of consciousness rather than hepatitis A
encephalopathy.
Although seizures are the most likely possibility,
the cause of the loss of consciousness in our patient
is unclear. Determining the cause of loss of
consciousness is dependent on clinical history, and
sometimes is difficult in the absence of clear
prodromal autonomic symptoms or convulsive
movements. This is particularly true in patients
with acute medical illness or fever. It is more likely
the seizures rather than syncope caused loss of
consciousness in this case as the patient had a
history of febrile convulsions and the symptoms
developed recurrently during acute illness periods.
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Although rare, reports of acute hepatitis A patients
with meningoencephalitis and suffering seizures1
may support the possibility of seizures in our case.
Several conditions can involve the corpus
callosum, including Marchiafava-Bignami disease,
multiple sclerosis, trauma, tumour, post-radiation
therapy, neoplasm and infarct.2 –5 However, clinical
profiles and imaging findings do not suggest these
Figure 1 MRI images in a patient with acute viral hepatitis A. (a) T2-weighted image on the second day after admission
shows a focal, ovoid hyperintense lesion in the splenium of the corpus callosum. (b) Non-contrast FLAIR image on the
same day as (a) shows a hyperintense lesion in the splenium of the corpus callosum. (c) T1-weighted image on the same
day as (a) shows an isointense to low-intensity signal in the splenium of the corpus callosum. (d) Follow-up T2-weighted
images 1-year later show complete disappearance of the splenial lesion.
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conditions affected the present patient. This
patient had no history of trauma or radiation.
Although Marchiafava-Bignami disease may cause
lesions in the splenium of the corpus callosum,5 the
patient did not drink alcohol, was not a drug abuser
and had a good nutritional state. The complete
resolution of the lesion without any treatment or
interventions ruled out the possibility of neoplasm
or infarct.
Similar focal lesions in the splenium of the corpus
callosum have been described in 21 epilepsy
patients. As focal splenium lesions in the corpus
callosum are rare, clarification of its pathogenesis
is difficult. Some authors have postulated that anti-
epileptic drug toxicity or the effect of anti-epileptic
drugs on arginine vasopressin hormone and fluid
balance is responsible.6 – 9 Although the lesions
occur mainly in epilepsy patients, Kim et al.6
identified such lesions in only six of 1200 patients
with epilepsy. This incidence is very low compared
with the number of patients receiving anti-epileptic
medication or with seizures. In that study, MRI
examinations were performed electively, and the
correlation between direct seizure activity and
splenium lesions was uncertain.
It has been suggested that lesions in the splenium
appear after recurrent focal seizures in the absence
of anti-epileptic drugs in epilepsy patients, and that
the focal oedema is due to seizure activity.10,11 One
study reported that early postictal apparent diffu-
sion coefficient (ADC) changes appeared to reflect
the origin and spread of the preceding seizure.12
The present patient was not taking any anti-
epileptic drugs and did not suffer from epilepsy.
Therefore, the focal lesion in the splenium of the
corpus callosum was not related to anti-epileptic
drug toxicity or drug effects on fluid balance. The
present case suggests that transient splenium
lesions are not unique to epilepsy patients.
There are two other literature reports of
transient isolated lesions in the splenium of the
corpus callosum, one in a rotavirus encephalopathy
patient and the other in an Escherichia coli-
associated haemolytic uraemic syndrome
patient.13,14 These reversible, MRI-detectable
changes represent transient local oedema in benign
infectious encephalopathy. The patient with rota-
virus encephalopathy had a generalized tonic clonic
seizure, so the role of seizure activity in the
splenium changes remained unclear.
An isolated focal splenium lesion in the corpus
callosum is very rare other than in epilepsy.
However, the present case, and two cases
described elsewhere,13,14 suggest such lesions are
not restricted to epilepsy patients or linked to anti-
epileptic drugs. These cases suggest isolated focal
splenium lesions can develop transiently, probably
due to focal oedema resulting from the infectious
process or related symptoms.
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